Macular Degeneration Screening
Macular Degeneration is a progressive eye disease and a leading cause of blindness, affecting more than 9 million people in the U.S. alone.
What is Macular Degeneration?
Macular Degeneration impacts the macula, an area of the retina where detailed central vision occurs. Numerous clinical studies have shown that dark adaptation-the recovery of vision when going from daylight to darkness-is dramatically impaired from the earliest stages of AMD and increases as the diseases progress.
Canton Ophthalmology Associates is excited to offer the Maculogix AdaptDx screening to our patients. This technology measures dark adaptation and along with an annual comprehensive examination, it can provide information to earlier detect macular damage and allow for prompt intervention.
Who is this test recommended for?
The AdaptDx screening is recommended for patients who are over 50 years of age or who have a family history of macular degeneration. It is also recommended for smokers and those who are overweight or who have poor night vision.
The screening takes no more than 6-7 minutes. Dilation may be necessary if your pupils are not large enough. Similar to other optometric tests, your head is placed in a machine and you are given instructions to push a button once a light appears. The doctor can then interpret the report with you.